Normal Risk Ovarian Screening Study: 21-Year Update

CY Han, KH Lu, G Corrigan, A Perez… - Journal of Clinical …, 2024 - ascopubs.org
Clinical trials frequently include multiple end points that mature at different times. The initial
report, typically based on the primary end point, may be published when key planned co …

OVANet: Dual Attention Mechanism based New Deep Learning Framework for Diagnosis and Classification of Ovarian Cancer Subtypes from Histopathological …

TA Fahim, FB Alam, KT Ahmmed - IEEE Access, 2024 - ieeexplore.ieee.org
This paper introduces OVANet, a new deep learning framework for the diagnosis and
classification of ovarian cancer subtypes from histopathological images. OVANet has been …

Development of label-free immunosensors based on AuNPs-fullerene nanocomposites for the determination of cancer antigen 125

U Kilimci, B Öndeş, Ç Sunna, M Uygun, DA Uygun - Bioelectrochemistry, 2025 - Elsevier
In this study, gold nanoparticles (AuNPs) were synthesized and combined with fullerene,
resulting in the formation of nanocomposite structures. The structures were then …

Protists and Cancer

A Sajjad, F Jabeen, S Zafar - … and Cancer: Understanding the Role of …, 2024 - Springer
Protists, a diverse group of eukaryotic unicellular microorganisms that are neither animals,
plants, nor fungi, protozoa have historically been investigated in relation to parasitic …

The prion-like protein Doppel: A soluble biomarker steering ovarian cancers peritoneal to circulatory dissemination

T Al-Hilal, MDZ Azam, X Zhang, R Wahab, MDM Hasan… - bioRxiv, 2024 - biorxiv.org
Detecting ovarian cancer (OC) early using existing biomarkers, eg, cancer antigen 125
(CA125), is challenging due to its ubiquitous expression in many tissues. Doppel, a prion …

A metabolite-based liquid biopsy for detection of ovarian cancer

JF Fahrmann, SM Ghasemi, CY Han, R Wu… - Biomarker …, 2024 - Springer
Serial CA125 and second line transvaginal ultrasound (TVS) screening in the UKCTOCS
indicated a shift towards detection of earlier stage ovarian cancer (OvCa), but did not yield a …